FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386407538> ?p ?o ?g. }

• W4386407538 abstract "Abstract Background Following resection and standard adjuvant radio- and chemotherapy, approved maintenance therapies for glioblastoma are lacking. Intracavitary radioimmunotherapy (iRIT) with 177 Lu-labeled 6A10-Fab fragments targeting tumor-associated carbonic anhydrase XII and injected into the resection cavity offers a novel and promising strategy for improved tumor control. Methods Three glioblastoma patients underwent tumor resection followed by standard radio- and chemotherapy. These patients with stable disease following completion of standard therapy underwent iRIT on compassionate grounds. After surgical implantation of a subcutaneous injection reservoir with a catheter into the resection cavity, a leakage test with [ 99m Tc]Tc-DTPA was performed to rule out leakage into other cerebral compartments. IRIT comprised three consecutive applications over three months for each patient, with 25%, 50%, 25% of the total activity injected. A dosimetry protocol was included with blood sampling and SPECT/CT of the abdomen to calculate doses for the bone marrow and kidneys as potential organs at risk. Results All three patients presented without relevant leakage after application of [ 99m Tc]Tc-DTPA. Two patients underwent three full cycles of iRIT (592 MBq and 1228 MBq total activity). One patient showed histologically proven tumor progression after the second cycle (526 MBq total activity). No relevant therapy-associated toxicities or adverse events were observed. Dosimetry did not reveal absorbed doses above upper dose limits for organs at risk. Conclusions In first individual cases, iRIT with [ 177 Lu]Lu-6A10-Fab appears to be feasible and safe, without therapy-related side effects. A confirmatory multicenter phase-I-trial was recently opened and is currently recruiting." @default.
• W4386407538 created "2023-09-05" @default.
• W4386407538 creator A5000854921 @default.
• W4386407538 creator A5027420105 @default.
• W4386407538 creator A5028012490 @default.
• W4386407538 creator A5033238501 @default.
• W4386407538 creator A5048807179 @default.
• W4386407538 creator A5053048077 @default.
• W4386407538 creator A5054404767 @default.
• W4386407538 creator A5064768052 @default.
• W4386407538 creator A5064834985 @default.
• W4386407538 creator A5067582099 @default.
• W4386407538 creator A5080069649 @default.
• W4386407538 date "2023-09-04" @default.
• W4386407538 modified "2023-10-15" @default.
• W4386407538 title "First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study" @default.
• W4386407538 cites W1140456871 @default.
• W4386407538 cites W1572121278 @default.
• W4386407538 cites W1974412135 @default.
• W4386407538 cites W2025799338 @default.
• W4386407538 cites W2028425564 @default.
• W4386407538 cites W2051768365 @default.
• W4386407538 cites W2085682224 @default.
• W4386407538 cites W2097512974 @default.
• W4386407538 cites W2107505074 @default.
• W4386407538 cites W2114874328 @default.
• W4386407538 cites W2135881288 @default.
• W4386407538 cites W2143235299 @default.
• W4386407538 cites W2143497943 @default.
• W4386407538 cites W2158392136 @default.
• W4386407538 cites W2187658107 @default.
• W4386407538 cites W2216442073 @default.
• W4386407538 cites W2289172605 @default.
• W4386407538 cites W2791179150 @default.
• W4386407538 cites W2902166104 @default.
• W4386407538 cites W2902484473 @default.
• W4386407538 cites W2936026334 @default.
• W4386407538 cites W3167909950 @default.
• W4386407538 cites W3197521059 @default.
• W4386407538 cites W4313813109 @default.
• W4386407538 doi "https://doi.org/10.1186/s13550-023-01029-7" @default.
• W4386407538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37665396" @default.
• W4386407538 hasPublicationYear "2023" @default.
• W4386407538 type Work @default.
• W4386407538 citedByCount "0" @default.
• W4386407538 crossrefType "journal-article" @default.
• W4386407538 hasAuthorship W4386407538A5000854921 @default.
• W4386407538 hasAuthorship W4386407538A5027420105 @default.
• W4386407538 hasAuthorship W4386407538A5028012490 @default.
• W4386407538 hasAuthorship W4386407538A5033238501 @default.
• W4386407538 hasAuthorship W4386407538A5048807179 @default.
• W4386407538 hasAuthorship W4386407538A5053048077 @default.
• W4386407538 hasAuthorship W4386407538A5054404767 @default.
• W4386407538 hasAuthorship W4386407538A5064768052 @default.
• W4386407538 hasAuthorship W4386407538A5064834985 @default.
• W4386407538 hasAuthorship W4386407538A5067582099 @default.
• W4386407538 hasAuthorship W4386407538A5080069649 @default.
• W4386407538 hasBestOaLocation W43864075381 @default.
• W4386407538 hasConcept C126322002 @default.
• W4386407538 hasConcept C126838900 @default.
• W4386407538 hasConcept C141071460 @default.
• W4386407538 hasConcept C159654299 @default.
• W4386407538 hasConcept C197934379 @default.
• W4386407538 hasConcept C203014093 @default.
• W4386407538 hasConcept C2776146153 @default.
• W4386407538 hasConcept C2776694085 @default.
• W4386407538 hasConcept C2989005 @default.
• W4386407538 hasConcept C542903549 @default.
• W4386407538 hasConcept C71924100 @default.
• W4386407538 hasConcept C75088862 @default.
• W4386407538 hasConceptScore W4386407538C126322002 @default.
• W4386407538 hasConceptScore W4386407538C126838900 @default.
• W4386407538 hasConceptScore W4386407538C141071460 @default.
• W4386407538 hasConceptScore W4386407538C159654299 @default.
• W4386407538 hasConceptScore W4386407538C197934379 @default.
• W4386407538 hasConceptScore W4386407538C203014093 @default.
• W4386407538 hasConceptScore W4386407538C2776146153 @default.
• W4386407538 hasConceptScore W4386407538C2776694085 @default.
• W4386407538 hasConceptScore W4386407538C2989005 @default.
• W4386407538 hasConceptScore W4386407538C542903549 @default.
• W4386407538 hasConceptScore W4386407538C71924100 @default.
• W4386407538 hasConceptScore W4386407538C75088862 @default.
• W4386407538 hasFunder F4320320876 @default.
• W4386407538 hasFunder F4320321114 @default.
• W4386407538 hasIssue "1" @default.
• W4386407538 hasLocation W43864075381 @default.
• W4386407538 hasLocation W43864075382 @default.
• W4386407538 hasOpenAccess W4386407538 @default.
• W4386407538 hasPrimaryLocation W43864075381 @default.
• W4386407538 hasRelatedWork W1970641137 @default.
• W4386407538 hasRelatedWork W2042837480 @default.
• W4386407538 hasRelatedWork W2087631306 @default.
• W4386407538 hasRelatedWork W2108213903 @default.
• W4386407538 hasRelatedWork W2158284291 @default.
• W4386407538 hasRelatedWork W2160751658 @default.
• W4386407538 hasRelatedWork W2165492210 @default.
• W4386407538 hasRelatedWork W2545086415 @default.
• W4386407538 hasRelatedWork W2899820134 @default.
• W4386407538 hasRelatedWork W3161464386 @default.
• W4386407538 hasVolume "13" @default.

• next